5-amino-2-nitrobenzoic acid

Skin irritation / corrosion

Administrative data

Endpoint:

skin irritation: in vitro / ex vivo

Type of information:

experimental study

Adequacy of study:

key study

Study period:

25 September - 27 September 2019

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2019

Report date:

2019

Materials and methods

Test guideline

Test guideline 1

Qualifier:

according to guideline

Guideline:

OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)

Version / remarks:

June 2019

Deviations:

no

Test guideline 2

Qualifier:

according to guideline

Guideline:

EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)

Version / remarks:

April 2017

Deviations:

no

Test guideline 3

Qualifier:

according to guideline

Guideline:

other: EURL ECVAM DB-ALM Protocol n° 131

Version / remarks:

June 2012

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Test material

Test material information

Constituent 1

Reference substance name:

5-amino-2-nitrobenzoic acid

EC Number:

236-283-4

EC Name:

5-amino-2-nitrobenzoic acid

Cas Number:

13280-60-9

Molecular formula:

C7H6N2O4

IUPAC Name:

5-amino-2-nitrobenzoic acid

impurity 1

Reference substance name:

Water

EC Number:

231-791-2

EC Name:

Water

Cas Number:

7732-18-5

Molecular formula:

H2O

IUPAC Name:

Oxidane

impurity 2

Reference substance name:

Unknown impurities.

Molecular formula:

Not available as unknown impurities.

IUPAC Name:

Unknown impurities.

Test material form:

solid

Details on test material:

Batch / Lot No. 10044431

Specific details on test material used for the study:

Batch-No.: 10044431
Storage: room temperature

In vitro test system

Test system:

human skin model

Remarks:

EpiSkin Small Model (three-dimensional human epidermis model) manufactured by EPISKIN SNC Lyon, France

Source species:

human

Cell type:

non-transformed keratinocytes

Justification for test system used:

The EPISKIN model has been validated for irritation testing in an international trial. After a review of scientific reports and peer reviewed publications on the EPISKIN method, it showed evidence of being a reliable and relevant stand-alone test for predicting rabbit skin irritation, when the endpoint is evaluated by MTT reduction and for being used as a replacement for the Draize Skin Irritation test (OECD TG 404 and Method B.4 of Annex V to Directive 67/548/EEC) for the purposes of distinguishing between skin irritating and
no- skin irritating test substances (STATEMENT OF VALIDITY OF IN-VITRO TESTS FOR SKIN IRRITATION; ECVAM; Institute for Health & Consumer Protection; Joint Research Centre; European Commission; Ispra; 27 April 2007).

Vehicle:

unchanged (no vehicle)

Details on test system:

RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EpiSkinTM Small Model
- Supplier: EPISKIN Laboratories 4, rue Alexander Fleming, 69366 Lyon Cedex 07 - France
- Tissue batch number(s): 19-EKIN-039
- Expiry date: 30 September 2019
- Date of initiation of testing: 25 September 2019

PRE-INCUBATION
The “maintenance medium” was pre-warmed to 37 °C. The appropriate number of an assay plate wells were filled with the pre-warmed medium (2 mL per well). The epidermis units were placed with the media below them, in contact with the epidermis into each prepared well and then incubated overnight at 37±1 °C in an incubator with 5±1 % CO2, =95 % humidified atmosphere.

NUMBER OF REPLICATE TISSUES FOR TEST ITEMS AND CONTROLS
Three replicates were used for the test item and positive and negative controls, respectively.

REMOVAL OF TEST MATERIAL AND CONTROLS (day 0)
After the incubation time, the EpiSkinTMSM units were removed and rinsed thoroughly with approximately 25 mL PBS 1x solution to remove all of the test material from the epidermal surface. The rest of the PBS was removed from the epidermal surface with suitable pipette tip linked to a vacuum source (care was taken to avoid the damage of epidermis).

POST-INCUBATION (day 0-2)
After rinsing the units were placed into the plate wells with fresh pre-warmed “maintenance medium” (2 mL/well) below them and then incubated for 42 hours (± 1 h) at 37±1 °C in an incubator with 5±1 % CO2, >=95 % humidified atmosphere.

MTT TEST (day 2)
After the 42 hours (± 1h) incubation, the EpiSkinTMSM units were transferred into the MTT solution filled wells (2 mL of 0.3 mg/mL MTT per well) and then incubated for 3 hours (± 5 min) at 37±1°C in an incubator with 5±1 % CO2 protected from light, >=95 % humidified atmosphere.

FORMAZAN EXTRACTION (day 2)
At the end of incubation with MTT a formazan extraction was undertaken:
A disk of epidermis was cut from the unit (this involves the maximum area of the disk) using a biopsy punch (supplied as part of the kit). The epidermis was separated with the aid of forceps and both parts (epidermis and collagen matrix) were placed into a tube of 500 µL acidified isopropanol (one tube corresponding to one well of the tissue culture plate).
The capped tubes were thoroughly mixed by using a vortex mixer to achieve a good contact of all of the material with the acidified isopropanol then incubated for approximately four hours at room temperature protected from light with gentle agitation (~150 rpm) for formazan extraction. At the middle and at the end of the incubation period, each tube was additionally mixed using a vortex mixer to help extraction.

CELL VIABILITY MEASUREMENTS (day 2)
Following the formazan extraction, 2×200 µL sample from each tube was placed into the wells of a 96-well plate (labelled appropriately) and read the OD (Absorbance / Optical Density) of the samples in a 96-well plate spectrophotometer (Thermo Scientific; Multiscan FC) at 570 nm (±10 nm; Read out range: 0-3.5 Abs, Linearity range: 0.2136 – 3.1752) using acidified isopropanol solution as the blank (6×200 µL).

PREDITCTION MODEL / DECISION CRITERIA
The test chemical is identified as requiring classification and labelling according to UN GHS (Category
2 or Category 1), if the mean relative viability after 15 minutes exposure and 42 hours post incubation
is less or equal to 50% of the negative control.

Control samples:

yes, concurrent negative control

yes, concurrent positive control

Amount/concentration applied:

TEST MATERIAL
- Test item: The epidermal surface was first moistened with 5 µL deionised water* in order to improve further contact between powder and epidermis. Subsequently, approximately 10 mg of the test item was applied evenly to the epidermal surface. The test item was spread gently with a curved flat spatula in order to cover evenly all the skin surface if necessary.
*prepared by MILLIPORE Synergy UV HF ASTM 1: F8JA80461C in Toxi-Coop ZRT.

POSITIVE CONTROL
- Amount applied: 10µL
- Concentration: 1x PBS (Phosphate Buffered Saline)

NEGATIVE CONTROL
- Amount applied: 10 µL
- Concentration: SDS (Sodium Dodecyl Sulphate) 5% aq. solution

Duration of treatment / exposure:

15 minutes (± 0.5 min)

Duration of post-treatment incubation (if applicable):

42 hours (± 1h)

Number of replicates:

Three replicates were used for the test item and controls, respectively

Results and discussion

In vitro

Results

Irritation / corrosion parameter:

% tissue viability

Value:

90

Negative controls validity:

valid

Positive controls validity:

valid

Remarks on result:

no indication of irritation

Remarks:

mean viability value of three tissues

Other effects / acceptance of results:

OTHER EFFECTS
- Possible direct MTT reduction with test item: No colour change was observed after three hours of incubation. The test material did not interact with the MTT, therefore additional controls and data calculations were not necessary. A false estimation of viability can be precluded.
- Colouring potential of test item: As the test item has an intrinsic colour (yellow), two additional test item-treated tissues were used for the non-specific OD evaluation. Mean OD (measured at 570 nm) of these tissues was determined as 0.014. The Non Specific Colour % (NSCliving %) was calculated as 1.5 %. Therefore additional data calculation was not necessary. A false estimation of viability can be precluded.

ACCEPTANCE OF RESULTS
- Acceptance criteria met for negative control: Mean OD value 0.978 and standard deviation value (SD) for the % viability 100 (The mean OD value of the three negative control tissues should be between 0.6 and 1.5 and the standard deviation value (SD) of the % viability should be = or < 18)
- Acceptance criteria met for positive control: 4.33% mean viability range standard deviation value (SD) for the % viability 16 (The acceptable mean percentage viability range for positive controls is 0-40% and the standard deviation value (SD) of the % viability should be = or < 18.)
- For test chemicals, the standard deviation value (SD) of the % viability should be = or < 18 : 10.4 % SD

Any other information on results incl. tables

Cell viability The results of the optical density (OD) measured at 570 nm of each replicate and the calculated % viability of the cells is presented below:

Negative Control (1x PBS):

Replicate	Optical Density (OD)	Viability (%)
1	0.978	100
2	0.993	102
3	0.962	98
Mean	0.978	100
Standard Deviation (SD)		1.59

Positive Control (SDS 5% aq. solution):

Replicate	Optical Density (OD)	Viability (%)
1	0.182	19
2	0.111	11
3	0.187	19
Mean	0.160	16
Standard Deviation (SD)		4.33

Test item:

Replicate	Optical Density (OD)	Viability (%)
1	0.966	99
2	0.911	93
3	0.769	79
Mean	0.882	90
Standard Deviation (SD)		10.4

OD Values and NSC_living % of additional control:

Additional colour control	Optical Density (OD)	Non Specific Colour % (NSCliving %)
5 -Amino-2 -Nitrobenzoic Acid (test item treated tissueswithout MTT incubation)	1  0.018 2 0.011 mean 0.014	1.5

Applicant's summary and conclusion

Interpretation of results:

GHS criteria not met

Conclusions:

The results obtained from this in vitro skin irritation test, using the EPISKIN model, indicated that the test item reveals no skin irritation potential under the utilised testing conditions. The test item 5-Amino-2-Nitrobenzoic Acid (CAS-No. 13280-60-9) is considered to be non-irritant to skin and is therefore not classified (UN GHS No Category).

Executive summary:

EpiSkin^TMSM test of 5-Amino-2-Nitrobenzoic Acid (CAS-No. 13280-60-9) has been performed to predict its irritation potential by measurement of its cytotoxic effect, as reflected in the MTT assay, according to the OECD Test Guideline No. 439,18 June 2019.

 

Disks of EPISKIN (three units) were treated with test item and incubated for 15 minutes (± 0.5 min) at room temperature. Exposure of test material was terminated by rinsing with PBS 1x solution. Epidermis units were then incubated at 37±1 °C for 42 hours (± 1 h) in an incubator with 5±1 % CO₂,>=95 % humidified atmosphere. The viability of each disk was assessed by incubating the tissues for 3 hours (± 5 min) with MTT solution at 37±1 °C in 5±1 % CO₂ protected from light. The precipitated formazan was then extracted using acidified isopropanol and quantified spectrophotometrically.

 

The test item has an intrinsic colour (yellow), therefore two additional test item treated tissues were used for the non-specific OD evaluation. SDS (5 % aq.) and 1×PBS treated (three units / positive and negative control) epidermis were used as positive and negative controls respectively. For each treated tissue viability was expressed as a percentage relative to negative control.

 

The test chemical is identified as requiring classification and labelling according to UN GHS (Category 2 or Category 1), if the mean relative viability after 15 minutes exposure and 42 hours post incubation is less or equal (=) to 50 % of the negative control.

 

In this in vitro skin irritation test using the EPISKIN model, the test item 5-Amino-2-Nitrobenzoic Acid did not show significantly reduced cell viability in comparison to the negative control (mean value: 90 %). All obtained test item viability results were far above 50 % when compared to the viability values obtained from the negative control. Therefore the test item was considered to be non-irritant to skin.

 

Positive and negative controls showed the expected cell viability values within acceptable limits. The experiment was considered to be valid.

 

The results obtained from this in vitro skin irritation test, using the EPISKIN model, indicated that the test item reveals no skin irritation potential under the utilised testing conditions. The test item 5-Amino-2-Nitrobenzoic Acid (CAS-No. 13280-60-9) is considered to be non-irritant to skin and is therefore not classified (UN GHS No Category).